Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Neurological Disorders|April 10, 2026
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomesStefano Ziccardi, Damiano Marastoni, Pietro Biasi, et al.
Biomedicines|December 23, 2022
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTsValentina Mazziotti, Francesco Crescenzo, Agnese Tamanti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 23, 2024
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter DamageStefano Ziccardi, Agnese Tamanti, Claudia Ruggieri, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 30, 2021
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis PhenotypesIlaria Boscolo Galazzo, Lorenza Brusini, Muge Akinci, et al.
Annals of Clinical and Translational Neurology|January 23, 2021
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosisRoberta Magliozzi, Marco Pitteri, Stefano Ziccardi, et al.
Multiple Sclerosis and Related Disorders|February 24, 2026
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosisStefano Ziccardi, Tom A Fuchs, Luigi Martinelli, et al.
Annals of Clinical and Translational Neurology|July 8, 2026
Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple SclerosisStefano Ziccardi, Damiano Marastoni, Agnese Tamanti, et al.
Journal of Neurology|February 15, 2025
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bandsDamiano Marastoni, Monica Sicchieri, Francesca B Pizzini, et al.
Frontiers in Immunology|February 26, 2024
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosisDamiano Marastoni, Matteo Foschi, Chiara Eccher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2024
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple SclerosisDamiano Marastoni, Ermanna Turano, Agnese Tamanti, et al.
Pageof 4